Cardiolipin Antibodies Clinical Trials

• Immunotherapy of Cancer Using Donor Lymphocytes Labelled with in-Vitro Bispecific Antibodies.
  ClinicalTrials.gov Identifier: NCT00149019 - Recruiting
  Metastatic Solid Tumors
  
• A Retrospective Review - Anti-HLA Antibodies
  ClinicalTrials.gov Identifier: NCT00460824 - Active, not recruiting
  Congenital Disorders
  
• Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies
  ClinicalTrials.gov Identifier: NCT00492466 - Active, not recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®
  ClinicalTrials.gov Identifier: NCT00269477 - Active, not recruiting
  Meningitis; Meningococcal Infection
  
• Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Patients With Acquired Hemophilia A
  ClinicalTrials.gov Identifier: NCT00306670 - Not yet recruiting
  Acquired Hemophilia A Pts Who Have Developed Anti-Factor VIII Antibodies.
  
• Generation of Standard Laboratory Values for Pneumococci Antibodies
  ClinicalTrials.gov Identifier: NCT00567632 - Active, not recruiting
  Reference Values
  
• Is IFN-Beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta
  ClinicalTrials.gov Identifier: NCT00493116 - Active, not recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Long Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of Age
  ClinicalTrials.gov Identifier: NCT00386789 - Active, not recruiting
  Typhoid Fever
  
• Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies
  ClinicalTrials.gov Identifier: NCT00581763 - Recruiting
  Lupus
  
• The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys
  ClinicalTrials.gov Identifier: NCT00031109 - Active, not recruiting
  HIV Infections
  
• Rituximab Treatment to Block HLA Antibodies in Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00261547 - Recruiting
  Chronic Rejection; Kidney Insufficiency
  
• Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003338 - Active, not recruiting
  Lymphoma
  
• LMP2a-Specific Cytotoxic T-Lymphocytes Following CD45 Antibody for Lymphoma
  ClinicalTrials.gov Identifier: NCT00082225 - Active, not recruiting
  Lymphoma
  
• Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™
  ClinicalTrials.gov Identifier: NCT00445185 - Recruiting
  Hepatitis B
  
• Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.
  ClinicalTrials.gov Identifier: NCT00180817 - Recruiting
  Antiphospholipid Syndrome
  
• Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients
  ClinicalTrials.gov Identifier: NCT00317668 - Recruiting
  Epilepsy
  
• Effects of Antibodies to White Blood Cells on Platelet Transfusion Patients
  ClinicalTrials.gov Identifier: NCT00460122 - Recruiting
  Healthy; Transfusion Reactions
  
• Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®
  ClinicalTrials.gov Identifier: NCT00258856 - Active, not recruiting
  Meningitis; Meningococcal Infection
  
• Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy
  ClinicalTrials.gov Identifier: NCT00493077 - Recruiting
  Multiple Sclerosis
  
• Impact of Anti-TNF Antibodies on the T-Lymphocyte and Macrophage Cooperation in the Crohn Disease
  ClinicalTrials.gov Identifier: NCT00561548 - Recruiting
  Crohn Disease
  
• Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases
  ClinicalTrials.gov Identifier: NCT00327093 - Recruiting
  Colorectal Cancer; Neoplasm Metastasis
  
• Blood Test for Ovarian Cancer Associated Antibodies (CAAb)
  ClinicalTrials.gov Identifier: NCT00327925 - Recruiting
  Ovarian Cancer
  
• A Study to Collect Information About Risk Factors in the Development of a Rare Form of Anemia (Pure Red Cell Aplasia; PRCA) and Antibodies to Erythropoietin From Patients With Kidney Disease Treated With Epoetin Alfa
  ClinicalTrials.gov Identifier: NCT00211068 - Active, not recruiting
  Red-Cell Aplasia, Pure; Kidney Failure, Chronic
  
• Anti-Human CD45 Monoclonal Antibodies in Patients with Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00057005 - Recruiting
  Leukemia
  
• Antibodies to Digoxin for Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00550576 - Recruiting
  Bipolar Disorder
  
• Reasons for Non-Treatment of Hepatitis C in HCV Mono-Infected Patients Versus HCV-HIV co-Infected Patients in a University Setting
  ClinicalTrials.gov Identifier: NCT00222859 - Recruiting
  HIV Infections; Hepatitis C Antibodies
  
• Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery
  ClinicalTrials.gov Identifier: NCT00237328 - Recruiting
  Thrombosis; Thoracic Surgery
  
• Monoclonal Antibodies in Treating Patients with Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00056043 - Active, not recruiting
  recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent grade 3 follicular lymphoma
  
• Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy
  ClinicalTrials.gov Identifier: NCT00517101 - Not yet recruiting
  Psoriatic Arthritis; Ankylosing Spondylitis; Undifferentiated Spondyloarthropathy
  
• Breast Cancer Associated Antibodies
  ClinicalTrials.gov Identifier: NCT00331942 - Recruiting
  Breast Cancer
  
• A Study to Observe Patients with Anemia Treated with Recombinant Erythropoietins Who Develop Antibodies to Erythropoietin
  ClinicalTrials.gov Identifier: NCT00210977 - Not yet recruiting
  Anemia
  
• Treatment of HER2-Positive Metastatic Breast Cancer with Herceptin and Bevacizumab (antibodies against HER2 and VEGF)
  ClinicalTrials.gov Identifier: NCT00095706 - Recruiting
  Breast Cancer
  
• A Prospective, Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia (Aplastic Anemia) Mediated by Erythropoietin Antibodies Among Patients With Chronic Kidney Failure and Subcutaneous Exposure to Recombinant Erythropoietin Products
  ClinicalTrials.gov Identifier: NCT00391287 - Recruiting
  Erythropoietin, Recombinant; Kidney Failure, Chronic; Pure Red-Cell Aplasia; Red-Cell Aplasia, Pure
  
• Phase I/II, Open-Label Trial of Three Monoclonal Antibodies
  ClinicalTrials.gov Identifier: NCT00219986 - Completed
  HIV Infections
  
• Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine
  ClinicalTrials.gov Identifier: NCT00310713 - Completed
  Prevention of Meningococcal Infection
  
• Heparin Antibodies in Intensive Care Unit Patients (HAICU)
  ClinicalTrials.gov Identifier: NCT00283322 - Completed
  Heparin-Induced Thrombocytopenia
  
• Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
  ClinicalTrials.gov Identifier: NCT00430547 - Completed
  Graves' Ophthalmopathy
  
• Long-Term Follow-up of Measles Antibodies
  ClinicalTrials.gov Identifier: NCT00168571 - Completed
  Measles
  
• Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children
  ClinicalTrials.gov Identifier: NCT00163618 - Completed
  Encephalitis, Tick-Borne
  
• Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies
  ClinicalTrials.gov Identifier: NCT00004851 - Completed
  Hepatitis C
  
• Rituximab to Treat Neuropathy with Anti-MAG Antibodies
  ClinicalTrials.gov Identifier: NCT00050245 - Completed
  Polyneuropathies
  
• A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) and/or Antibodies to Erythropoietin While Receiving Epoetin Alfa or Another Recombinant Erythropoietin
  ClinicalTrials.gov Identifier: NCT00210951 - Completed
  Red-Cell Aplasia, Pure
  
• Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5ml in Adults Aged 18 - 67 Years
  ClinicalTrials.gov Identifier: NCT00161785 - Completed
  Tick-Borne Encephalitis
  
• Role of Antibodies in Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00042523 - Completed
  Systemic Lupus Erythematosus
  
• An Epidemiological Study of Subjects with Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
  ClinicalTrials.gov Identifier: NCT00005570 - Completed
  Purpura, Thrombocytopenic, Idiopathic; immune thrombocytopenic purpura
  
• IC14 Antibodies to Treat Individuals With Acute Lung Injury
  ClinicalTrials.gov Identifier: NCT00233207 - Terminated
  Respiratory Distress Syndrome, Adult; Lung Diseases
  
• Correlation of FC Gamma RIIA Receptor Response in Patients with Waldenstrom''s Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00142155 - Terminated
  Waldenstrom''s Macroglobulinemia